Auteur B. A. G. DIJKSTRA

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders

P. J. CARPENTIER ; C. A. J. DE JONG ; B. A. G. DIJKSTRA ; C. A. G. VERBRUGGE ; P. F. M. KRABBE | 2005
Périodique

Aims: Attention delicit/hyperactivity disorder (ADHD) is common among adult patients with substance use disorders. The benefits of treating ADHD in these patients are uncertain and the prescription of psychostimulants is disputed, because of the[...]

Plus d'info

Ajouter à la sélection

Development of the Gamma-Hydroxybutyrate Withdrawal Symptom Questionnaire

A. M. L. WOOD ; A. F. A. SCHELLEKENS ; B. A. G. DIJKSTRA ; C. J. H. WOLF ; H. BEURMANJER | 2025
Dans European Addiction Research (Vol.31, n°3, August 2025) Article : Périodique

INTRODUCTION: Gamma-hydroxybutyrate (GHB) dependence has been associated with a potentially fulminant withdrawal syndrome. As GHB withdrawal symptoms can rapidly progress from mild to more severe, close monitoring during detoxification is import[...]

Plus d'info

Ajouter à la sélection

Lien externe

Unity in diversity: A systematic review on the GHB using population

B. A. G. DIJKSTRA ; H. BEURMANJER ; A. E. GOUDRIAAN ; A. F. A. SCHELLEKENS ; E. A. G. JOOSTEN | 2021
Dans International Journal of Drug Policy (Vol.94, August 2021) Article : Périodique

Background: Over the past decades gamma-hydroxybutyrate (GHB) has emerged as a popular drug with high potential of (ab)use due to its euphoric and relaxing effects. An overview of different populations using GHB is urgently needed, since this wo[...]

Plus d'info

Ajouter à la sélection